Description
Tirzepatide (GLP-1/GIP) 15mg is a synthetic dual incretin receptor agonist peptide studied in preclinical and clinical research for GLP-1 and GIP receptor binding kinetics and metabolic signaling pathway analysis. Available exclusively for licensed research and laboratory use.
Research Background
Tirzepatide has been investigated in peer-reviewed studies examining dual GLP-1/GIP receptor agonism and associated physiological signaling mechanisms. References are provided for informational purposes relating to published scientific literature.
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. Must be handled by licensed, qualified professionals in a controlled laboratory setting.
Research Resources
For research purposes only. Not for human use.












